{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:33:18Z","timestamp":1789687998306,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,20]]},"DOI":"10.7759\/cureus.52608","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T09:59:26Z","timestamp":1705744766000},"source":"Crossref","is-referenced-by-count":6,"title":["Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia"],"prefix":"10.7759","author":[{"given":"Ahmed M","family":"Badheeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed K","family":"Al Sedran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim K","family":"Al Sidran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed H","family":"Al Qurayshah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Abu Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamoud Y","family":"Obied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam A","family":"Seada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelaziz","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Badheeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag HB","year":"2007","unstructured":"El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007, 132:2557-76. 10.1053\/j.gastro.2007.04.061","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong RJ","year":"2014","unstructured":"Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014, 59:2188-95. 10.1002\/hep.26986","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978-2012","volume":"147","author":"Petrick JL","year":"2020","unstructured":"Petrick JL, Florio AA, Znaor A, et al.. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 2020, 147:317-30. 10.1002\/ijc.32723","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia","volume":"42","author":"Zhang CH","year":"2022","unstructured":"Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q. Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int. 2022, 42:2029-41. 10.1111\/liv.15251","journal-title":"Liver Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S232600","article-title":"The incidence rate of liver cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry (2004-2014)","volume":"12","author":"Alghamdi IG","year":"2020","unstructured":"Alghamdi IG, Alghamdi MS. The incidence rate of liver cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry (2004-2014). Cancer Manag Res. 2020, 12:1101-11. 10.2147\/CMAR.S232600","journal-title":"Cancer Manag Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7612","article-title":"Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population","volume":"13","author":"Alswat KA","year":"2013","unstructured":"Alswat KA, Sanai FM, Altuwaijri M, Albenmousa A, Almadi M, Al-Hamoudi WK, Abdo AA. Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population. Hepat Mon. 2013, 13:e7612. 10.5812\/hepatmon.7612","journal-title":"Hepat Mon"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000710","article-title":"Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis","volume":"261","author":"Tabrizian P","year":"2015","unstructured":"Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015, 261:947-55. 10.1097\/SLA.0000000000000710","journal-title":"Ann Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092550","article-title":"Child-Pugh Score and ABCG2-rs2231142 genotype independently predict survival in advanced hepatoma patients treated with sorafenib","volume":"11","author":"Huang PH","year":"2022","unstructured":"Huang PH, Yu J, Chu YY, Lin YH, Yeh CT. Child-Pugh Score and ABCG2-rs2231142 genotype independently predict survival in advanced hepatoma patients treated with sorafenib. J Clin Med. 2022, 11:2550. 10.3390\/jcm11092550","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014070","article-title":"Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China","volume":"98","author":"Wang CY","year":"2019","unstructured":"Wang CY, Li S. Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China. Medicine. 2019, 98:e14070. 10.1097\/MD.0000000000014070","journal-title":"Medicine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14811","article-title":"Revealing hepatitis b virus as a silent killer: a call-to-action for Saudi Arabia","volume":"13","author":"Alghamdi M","year":"2021","unstructured":"Alghamdi M, Alghamdi AS, Aljedai A, et al.. Revealing hepatitis b virus as a silent killer: a call-to-action for Saudi Arabia. Cureus. 2021, 13:e14811. 10.7759\/cureus.14811","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure","volume":"41","author":"Polson J","year":"2005","unstructured":"Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005, 41:1179-97. 10.1002\/hep.20703","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.889188","article-title":"Human albumin: old, new, and emerging applications","volume":"18","author":"Rozga J","year":"2013","unstructured":"Rozga J, Pi\u0105tek T, Ma\u0142kowski P. Human albumin: old, new, and emerging applications. Ann Transplant. 2013, 18:205-17. 10.12659\/AOT.889188","journal-title":"Ann Transplant"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i23.3290","article-title":"Viscoelastic tests in liver disease: where do we stand now?","volume":"27","author":"Buliarca A","year":"2021","unstructured":"Buliarca A, Horhat A, Mocan T, Craciun R, Procopet B, Sparchez Z. Viscoelastic tests in liver disease: where do we stand now?. World J Gastroenterol. 2021, 27:3290-302. 10.3748\/wjg.v27.i23.3290","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5628","article-title":"Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma","volume":"31","author":"The Cancer of the Liver Italian Program (CLIP) Investigators","year":"2000","unstructured":"The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology. 2000, 31:840-5. 10.1053\/he.2000.5628","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani C","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, et al.. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018, 391:1023-75. 10.1016\/S0140-6736(17)33326-3","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2012.174","article-title":"Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines","volume":"32","author":"Abdo AA","year":"2012","unstructured":"Abdo AA, Hassanain M, AlJumah A, et al.. Saudi guidelines for the diagnosis and management of hepatocellular carcinoma: technical review and practice guidelines. Ann Saudi Med. 2012, 32:174-99. 10.5144\/0256-4947.2012.174","journal-title":"Ann Saudi Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich G","year":"2004","unstructured":"Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004, 127:S35-50. 10.1053\/j.gastro.2004.09.014","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1989045","article-title":"Clinical presentation, risk factors, and treatment modalities of hepatocellular carcinoma: a single tertiary care center experience","volume":"2016","author":"Aljumah AA","year":"2016","unstructured":"Aljumah AA, Kuriry H, AlZunaitan M, et al.. Clinical presentation, risk factors, and treatment modalities of hepatocellular carcinoma: a single tertiary care center experience. Gastroenterol Res Pract. 2016, 2016:1989045. 10.1155\/2016\/1989045","journal-title":"Gastroenterol Res Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2018.57","article-title":"Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries","volume":"4","author":"Yapali S","year":"2018","unstructured":"Yapali S, Tozun N. Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries. Hepatoma Res. 2018, 4:24. 10.20517\/2394-5079.2018.57","journal-title":"Hepatoma Res"},{"key":"ref21","article-title":"Profile of viral hepatitis in Saudi Arabia","volume":"8","author":"Alshabanat A","year":"2014","unstructured":"Alshabanat A, R. B. Albacker, A. A. Basalama, Salamah AAB, Alfrayh AS. Profile of viral hepatitis in Saudi Arabia. Int J Med Health Biomed Bioeng Pharma Eng. 2014, 8:492-7.","journal-title":"Int J Med Health Biomed Bioeng Pharma Eng"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao K","year":"2019","unstructured":"Tarao K, Nozaki A, Ikeda T, et al.. Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment. Cancer Med. 2019, 8:1054-65. 10.1002\/cam4.1998","journal-title":"Cancer Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2023.07.008","article-title":"Hepatitis B virus infection in Saudi Arabia and the UAE: public health challenges and their remedial measures","volume":"16","author":"Sanai F","year":"2023","unstructured":"Sanai F, Alkhatry M, Alzanbagi A, Kumar S. Hepatitis B virus infection in Saudi Arabia and the UAE: public health challenges and their remedial measures. J Infect Public Health. 2023, 16:1410-7. 10.1016\/j.jiph.2023.07.008","journal-title":"J Infect Public Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2005.08.021","article-title":"Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved","volume":"38","author":"Guyot C","year":"2006","unstructured":"Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, Desmouli\u00e8re A. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol. 2006, 38:135-51. 10.1016\/j.biocel.2005.08.021","journal-title":"Int J Biochem Cell Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v11.i1.1","article-title":"Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review","volume":"11","author":"Desai A","year":"2019","unstructured":"Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019, 11:1-18. 10.4254\/wjh.v11.i1.1","journal-title":"World J Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2020.1788139","article-title":"Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites?","volume":"55","author":"Kim KM","year":"2020","unstructured":"Kim KM, Shim SG, Sinn DH, Song JE, Kim BS, Kim HG. Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites?. Scand J Gastroenterol. 2020, 55:951-7. 10.1080\/00365521.2020.1788139","journal-title":"Scand J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002877","article-title":"Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"95","author":"Peng Y","year":"2016","unstructured":"Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine. 2016, 95:e2877. 10.1097\/MD.0000000000002877","journal-title":"Medicine"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300301","article-title":"Evaluation of multiple liver cancer scoring systems","author":"Sun J","year":"2023","unstructured":"Sun J, Qi C, Liu Y, Gao F, Fu X, Tian Y. Evaluation of multiple liver cancer scoring systems. Adv Biol. 2023, e2300301. 10.1002\/adbi.202300301","journal-title":"Adv Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/13651820310015833","article-title":"AHPBA\/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement","volume":"5","author":"Henderson JM","year":"2003","unstructured":"Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T. AHPBA\/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB. 2003, 5:243-50. 10.1080\/13651820310015833","journal-title":"HPB"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i21.3207","article-title":"Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases","volume":"19","author":"Fenoglio L","year":"2013","unstructured":"Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases. World J Gastroenterol. 2013, 19:3207-16. 10.3748\/wjg.v19.i21.3207","journal-title":"World J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"15","author":"Zhang J","year":"2020","unstructured":"Zhang J, Chen G, Zhang P, et al.. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLoS One. 2020, 15:e0228857. 10.1371\/journal.pone.0228857","journal-title":"PLoS One"},{"key":"ref32","article-title":"Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma","volume":"60","author":"Toader E","year":"2019","unstructured":"Toader E, Bancu A, Mitric\u0103 DE, Constantinescu G, \u015etef\u0103nescu G, B\u0103lan GG. Interrelations between elevated alpha-fetoprotein levels and tumor morphology of patients with hepatocellular carcinoma. Rom J Morphol Embryol. 2019, 60:181-7.","journal-title":"Rom J Morphol Embryol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19531-8","article-title":"Association of alpha-fetoprotein and metastasis for small hepatocellular carcinoma: a propensity-matched analysis","volume":"12","author":"Wang YQ","year":"2022","unstructured":"Wang YQ, Wang AJ, Zhang TT, Chen SH. Association of alpha-fetoprotein and metastasis for small hepatocellular carcinoma: a propensity-matched analysis. Sci Rep. 2022, 12:15676. 10.1038\/s41598-022-19531-8","journal-title":"Sci Rep"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-011-9338-z","article-title":"Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy","volume":"7","author":"Hsu CY","year":"2013","unstructured":"Hsu CY, Lee YH, Huang YH, et al.. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy. Hepatol Int. 2013, 7:188-98. 10.1007\/s12072-011-9338-z","journal-title":"Hepatol Int"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.08.019","article-title":"Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma","volume":"9","author":"Yang JD","year":"2011","unstructured":"Yang JD, Kim WR, Coelho R, et al.. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011, 9:64-70. 10.1016\/j.cgh.2010.08.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","article-title":"Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience","volume":"10","author":"Hsu WF","year":"2020","unstructured":"Hsu WF, Chuang PH, Chen CK, et al.. Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience. Am J Cancer Res. 2020, 10:4547-60.","journal-title":"Am J Cancer Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3370992","article-title":"Clinical characteristics of patients with hepatocellular carcinoma: a single-center 3-year experience from Somalia","volume":"2022","author":"Hassan-Kadle MA","year":"2022","unstructured":"Hassan-Kadle MA, Osman MM, Keles E, Eker HH, Baydili KN, Ahmed HM, Osman AA. Clinical characteristics of patients with hepatocellular carcinoma: a single-center 3-year experience from Somalia. Int J Hepatol. 2022, 2022:3370992. 10.1155\/2022\/3370992","journal-title":"Int J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/215984-clinical-characteristics-and-survival-of-hepatocellular-carcinoma-insights-from-single-centre-experience-in-saudi-arabia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:16:48Z","timestamp":1707509808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/215984-clinical-characteristics-and-survival-of-hepatocellular-carcinoma-insights-from-single-centre-experience-in-saudi-arabia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.52608","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,20]]}}}